HOME >> BIOLOGY >> NEWS
Evidence that adults stem cells differentiate like embryonic stem cells published in Nature

MINNEAPOLIS / ST. PAUL(June 18, 2002)--Researchers at the University of Minnesota Stem Cell Institute (SCI) have found the first evidence that adult bone marrow-derived cells can differentiate in vitro and in vivo into cells of all three embryonic germ layers (endoderm, ectoderm and mesoderm) in similar manner as embryonic stem cells (ES cells). SCI Director Catherine Verfaillie, M.D., and her colleagues call these cells multipotent adult progenitor cells (MAPCs). The results of the research are published by Nature and will be available online Thursday, June 20, 2002, at http://www.nature.com/nature. The results will be presented at 9:30 a.m. the same day at a press conference in Minnesota. Verfaillie, the lead researcher, reports that cells grown from adult mouse and rat bone marrow can be cultured without aging and with active telomerase, an enzyme found in embryonic stem cells that prevents aging.

In subsequent studies, Verfaillie's lab showed that single MAPCs can contribute to most, if not all, tissues of mice after they have been injected into the blastocyst of a mouse. The result is a chimerical animal. "This occurs with one out of every three cells, and contribution is to all tissues of the mouse," said Verfaillie. "Some of the animals are 40 percent derived from the bone marrow stem cells, suggesting that the cells contribute functionally to a number of organs. Again, this is similar to what one would expect of ES cells.

"In contrast to ES cells, when we inject the bone marrow stem cells into recipient animals, the bone marrow stem cells do not form teratomas [tumors containing many different tissue types], but respond to local cues and differentiate into blood cells as well as into epithelium of liver, gut, and lung."

In response to recent critics of the potential of adult stem cells, Verfaillie's research shows in vitro that a single cell differentiates into cells of the three germ laye
'"/>

Contact: Deane Morrison
morri029@umn.edu
612-624-2346
University of Minnesota
20-Jun-2002


Page: 1 2 3

Related biology news :

1. Evidence builds for potential new cancer drug target
2. Evidence for sympatric speciation by host shift in the sea
3. Evidence for the impact of climate change on deep-sea biodiversity
4. Evidence for fat hormone target in brain
5. Evidence of nanobacterial-like structures found in human calcified arteries and cardiac valves
6. Evidence shows the heart has stem cells able to regenerate muscle tissue lost to disease, wear
7. Evidence for orangutan culture
8. Evidence suggests that standard smallpox vaccine offers long-term immunity
9. When Shewanella meets goethite: Evidence found of recognition between animate and inanimate objects
10. Evidence links protein damage to Parkinsons
11. Evidence suggests food preservatives may help prevent cavities

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/7/2020)... ... 07, 2020 , ... dicentra , a leading clinical ... and dietary supplement industries, announces 2020 membership with the International Probiotics Association (“IPA”). ... pertaining to probiotics. We are thrilled to join our IPA member colleagues and ...
(Date:2/5/2020)... ... February 04, 2020 , ... Crystal Diagnostics (CDx) ... a second patent related to proprietary liquid crystal technology for rapid and accurate ... the USPTO issued on December 3, 2019. Together, these patents protect the company’s ...
(Date:1/30/2020)... , ... January 30, 2020 , ... Accelera Canada ... eye on the Canadian market, is pleased to announce that the company has opened ... since the company launched in 2017. , “We are so thrilled to now ...
Breaking Biology News(10 mins):
(Date:1/27/2020)... , ... January 27, 2020 , ... ... it has secured financing from strategic investors led by Halma plc , ... existing investors Sonion, TDF Ventures, GII LLC, and WSJ Joshua Fund. A representative ...
(Date:1/23/2020)... ... January 22, 2020 , ... Ideal Implant ... surgery industry at two recent North American investor forums specializing in medical advancements. ... Medical Technologies & Diagnostics Forum on November 21, 2019 in New York City, ...
(Date:1/22/2020)... ... 21, 2020 , ... QCDx , a private biotech company that has ... today announced the sale of the proprietary RareScope™ instrument to the Carole and Ray ... clinical cancer research. , “The RareScope can detect and isolate intact and live Circulating ...
(Date:1/8/2020)... ... 2020 , ... Anomet Products has introduced new ... in harsh environments inside or outside of the human body. , ... to achieve specific properties such as corrosion-resistance, biocompatibility, or operation at temperatures from ...
Breaking Biology Technology:
Cached News: